Visa Inc. (V) · Oct 27, 2026 · Earnings
Beat — Non-GAAP EPS $3.48 vs ~$3.43–$3.44 consensus; revenue $12.14B vs ~$12.08–$12.09B
Visa’s Q4 earnings beat consensus, with revenue and adjusted EPS ahead of estimates as cross-border volume surged 14%.
Visa enters this report as the dominant global payments network, still compounding through digital payments while repositioning around fraud prevention, AI-enabled commerce and trust. Its $2.4 billion BioCatch acquisition fits that strategy by adding behavioral fraud intelligence as scams and social engineering move beyond traditional payment-security defenses.
| Metric | Q4 FY2026 | Comparison / expectation |
|---|---|---|
| Net revenue | $12.14B | +13% YoY; consensus ~$12.08–$12.09B |
| Non-GAAP EPS | $3.48 | +17% YoY; consensus ~$3.43–$3.44 |
| Payments volume | +9% | Constant dollars, YoY |
| Cross-border volume | +14% | Constant dollars, YoY |
| Processed transactions | 74.2B | +10% YoY |
| Non-GAAP operating expenses | $4.05B | +12% YoY |
| Quarterly dividend | $0.780/share | +16% |
The quarter cleared an already-high bar, but only narrowly. Adjusted EPS of $3.48 exceeded the published consensus range of roughly $3.43–$3.44, while revenue of $12.14 billion was modestly ahead of estimates around $12.08–$12.09 billion. That makes this a genuine beat, but not a change in Visa’s basic trajectory: analysts were already expecting roughly 13% revenue growth and mid-teens EPS growth. Visa reported, “Net revenue in the fiscal fourth quarter was $12.1 billion, an increase of 13%.”
Cross-border remained the key upside engine. International activity grew faster than domestic payment volume, with cross-border volume up 14% and processed transactions up 10%; that supports Visa’s higher-margin international transaction business and shows continued strength in travel and global commerce. 〔0〕
Underlying growth was strong, but operating leverage was limited. Non-GAAP operating expenses rose 12%, almost matching the 13% revenue increase, while client incentives increased 21%. The result is still excellent profitability, but the filing does not show an accelerating margin story; more of the upside came from volume growth and share repurchases than from sharply widening cost leverage. Visa’s non-GAAP net income was $6.6 billion and non-GAAP EPS was $3.48, up 13% and 17%, respectively.
The strategic story advanced, but the next leg is still execution-dependent. Visa is using its network, fraud controls and acquisitions to defend trust as AI agents and scams reshape payments. The filing confirms the BioCatch deal remains on track for closing by the end of fiscal Q2 2027, but provides no new financial contribution or FY2027 operating outlook. Visa said the transaction “is expected to close by the end of the fiscal second quarter of 2027.” 〔1〕
Capital returns added a secondary positive signal. The board raised the quarterly dividend 16% to $0.780 per share, alongside $20.5 billion of fiscal-year repurchases. That reinforces Visa’s cash-generation profile, though it was broadly consistent with the company’s established capital-return model rather than a new strategic pivot.
Bottom line: Visa delivered a narrow earnings and revenue beat on broad, still-healthy payment growth, led by cross-border activity. It meaningfully supports the existing growth story, but does not yet reset expectations for the business or provide a new FY2027 outlook.
BioCatch closing expected by end of fiscal Q2 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!